| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | -0.055 | 0.3 |
| mRNA | ZG-10 | GDSC1000 | pan-cancer | AAC | -0.053 | 0.3 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | 0.04 | 0.3 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | XMD8-92 | GDSC1000 | pan-cancer | AAC | 0.056 | 0.3 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.3 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | 0.32 | 0.3 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.043 | 0.3 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | Roscovitine | FIMM | pan-cancer | AAC | -0.2 | 0.3 |